|
|
| 24.64 Data as of Apr 17 |  +0.16 / +0.65%Today’s Change | 17.00 Today|||52-Week Range 30.77 | -7.85% Year-to-Date |
| ABIOMED's Impella RP Bags CE Mark - Analyst Blog Apr 17 / Zacks.com | Abiomed Acquires Exclusive License for Opsens' Optical Sensor Technology Apr 15 / Benzinga |
| Previous close | 24.48 |
| Today’s open | 24.42 |
| Day’s range | 24.25 - 24.86 |
| Volume | 235,776 |
| Average volume (3 months) | 473,776 |
| Market cap | $953.2M |
| Dividend yield | -- |
| Earnings growth (last year) | +825.00% |
| Earnings growth (this year) | -55.68% |
| Earnings growth (next 5 years) | +21.50% |
| Revenue growth (last year) | +25.12% |
| P/E ratio | 136.9 |
| Price/Sales | 4.62 |
| Price/Book | 6.74 |
| Today’s change | Today’s % change | |
|---|---|---|
| TRNXTornier NV | +0.14 | +0.77% |
| OMCLOmnicell Inc | +0.24 | +0.89% |
| VOLCVolcano Corp | -0.06 | -0.31% |
| ABAXAbaxis Inc | +0.56 | +1.45% |
| Next reporting date | May 1, 2014 |
| EPS forecast (this quarter) | $0.07 |
| Annual revenue (last year) | $158.1M |
| Annual profit (last year) | $15.0M |
| Net profit margin | 9.50% |
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer Michael R. Minogue |
Chief Operating Officer David M. Weber |
Corporate headquarters Danvers, Massachusetts |
.
